Fortress Biotech, Inc. (FBIO) Q4 2024 Earnings Call Transcript

Stock Information for Fortress Biotech Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Fortress Biotech Inc.

Journey Medical Corporation to Announce First Quarter 2025 Financial Results on May 14, 2025
Fortress Biotech to Participate in the H.C. Wainwright 1st Annual Royalty Company Virtual Conference
Journey Medical Corporation Appoints Ramsey Alloush as Chief Operating Officer
Fortress Biotech Reports 2024 Financial Results and Recent Corporate Highlights
Checkpoint Therapeutics Reports Full-Year 2024 Financial Results and Recent Corporate Updates
Journey Medical Corporation Reports Full-Year 2024 Financial Results and Recent Corporate Highlights
Journey Medical Corporation Launches Emrosi(TM) (40 mg Minocycline Hydrochloride Modified-Release Capsules, 10 mg immediate release and 30 mg extended release) for the Treatment of Rosacea
Journey Medical Corporation to Announce Year End 2024 Financial Results on March 26, 2025

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.